1Life Healthcare, Inc. (NASDAQ:ONEM) shares saw an uptick in trading volume on Monday . 164,696 shares were traded during mid-day trading, a decline of 88% from the previous session’s volume of 1,351,553 shares.The stock last traded at $20.88 and had previously closed at $21.45.
A number of research firms have recently weighed in on ONEM. Canaccord Genuity cut their price objective on shares of 1Life Healthcare from $48.00 to $40.00 and set a “buy” rating on the stock in a research note on Thursday, August 5th. Piper Sandler cut their price objective on shares of 1Life Healthcare from $55.50 to $37.00 and set an “overweight” rating on the stock in a research note on Friday. Robert W. Baird downgraded shares of 1Life Healthcare from an “outperform” rating to a “neutral” rating and lowered their price target for the stock from $43.00 to $31.00 in a report on Monday, August 9th. Citigroup increased their price objective on shares of 1Life Healthcare from $46.00 to $55.00 and gave the company a “buy” rating in a report on Thursday, August 5th. Finally, SVB Leerink assumed coverage on shares of 1Life Healthcare in a report on Monday. They set a “market perform” rating and a $22.00 price objective on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $43.00.
The firm has a market capitalization of $2.83 billion, a price-to-earnings ratio of -27.50 and a beta of 1.27. The business’s 50-day simple moving average is $25.13 and its two-hundred day simple moving average is $32.99. The company has a quick ratio of 4.86, a current ratio of 4.89 and a debt-to-equity ratio of 0.65.
In related news, Director David P. Kennedy sold 2,778 shares of 1Life Healthcare stock in a transaction that occurred on Wednesday, August 18th. The shares were sold at an average price of $23.40, for a total value of $65,005.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold 8,334 shares of company stock valued at $207,267 in the last 90 days. Company insiders own 9.60% of the company’s stock.
A number of institutional investors have recently modified their holdings of the stock. Parametric Portfolio Associates LLC lifted its stake in 1Life Healthcare by 3.9% in the second quarter. Parametric Portfolio Associates LLC now owns 49,545 shares of the company’s stock worth $1,638,000 after acquiring an additional 1,841 shares during the last quarter. Integral Health Asset Management LLC purchased a new position in 1Life Healthcare in the second quarter worth approximately $1,653,000. Marshall Wace LLP purchased a new position in 1Life Healthcare in the second quarter worth approximately $370,000. Morgan Stanley lifted its stake in 1Life Healthcare by 27.5% in the second quarter. Morgan Stanley now owns 1,158,115 shares of the company’s stock worth $38,287,000 after acquiring an additional 250,082 shares during the last quarter. Finally, Walleye Capital LLC purchased a new position in 1Life Healthcare in the second quarter worth approximately $324,000. Institutional investors own 84.65% of the company’s stock.
1Life Healthcare Company Profile (NASDAQ:ONEM)
1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs.
Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.